pharmaceutical-investing Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
pharmaceutical-investing Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer
pharmaceutical-investing Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts
pharmaceutical-investing PADCEV Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
pharmaceutical-investing Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
pharmaceutical-investing Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
pharmaceutical-investing TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
pharmaceutical-investing Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
pharmaceutical-investing Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
pharmaceutical-investing Arvinas Announces Data Presentations from the Vepdegestrant Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium
pharmaceutical-investing U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
African Discovery Group announces signing of Definitive Sales and Purchase Agreement for Butembo Copper Asset in the Democratic Republic of Congo; name change to Copper Intelligence, Inc
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve "Project Vault" and Highlights Titanium's Strategic Importance to North American Defense Supply Chains
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026
